Table 3. Correlations between clinical, histological and molecular data and survival: Univariate and multivariate analysis.
Total cohort | OII | OIII | OIIIw | OIIId | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
EFS | OS | EFS | OS | EFS | OS | EFS | OS | EFS | OS | ||
Histological grade | Low / High grade | NS | NS | / | / | / | / | / | / | / | / |
Recurrence | No / Yes | 0.0003* | <0.0001* | / | / | 0.002 | <0.0001 | NS | 0.01 | 0.001 | 0.0001 |
Age at diagnosis | < 50 / ≥ 50 years | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS |
Sex | Male / Female | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS |
Extent of surgery | Biopsy / Surgery | NS | NS | NS | 0.003 | NS | NS | NS | NS | NS | NS |
Localization | Frontal / Other | 0.004 | 0.05 | NS | NS | 0.04 | NS | NS | NS | NS | NS |
Postoperative treatment | No / Yes | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS |
MVP | No / Yes | NS | NS | / | / | / | / | / | / | / | / |
Necrosis | No / Yes | 0.03 | 0.001 | / | / | 0.07 | 0.01 | NS | NS | NS | NS |
Calcifications | No / Yes | NS | 0.03 | NS | NS | NS | 0.04 | NS | NS | 0.05 | 0.04 |
Mitoses /10 HPF | < 5 / ≥ 5 | 0.02 | 0.0004 | NS | NS | 0.06 | 0.003 | 0.01 | 0.001 | 0.008 | 0.001 |
MIB1 | < 20 / ≥ 20% | 0.04 | 0.003 | NS | NS | 0.04 | 0.004 | 0.02 | 0.002 | 0.002 | <0.0001 |
INA | Negative / Positive | NS | NS | NS | NS | NS | NS | NS | NS | NS | NS |
p16 | < 12 / ≥ 12% | NS | NS | NS | 0.02 | NS | NS | NS | NS | NS | NS |
p16 | Expression Yes / No | NS | NS | / | / | NS | NS | NS | NS | 0.001 | 0.002 |
Cycline D1 | < 37 / ≥ 37% | 0.05 | 0.09 | NS | NS | 0.08 | NS | NS | NS | NS | NS |
Myc | < 35 / ≥ 35% | NS | NS | NS | NS | NS | NS | 0.01 | NS | NS | NS |
Chr 9p | Deletion / None | <0.0001* | <0.0001* | / | / | 0.0004 | 0.001 | / | / | / | / |
EFS: Event Free Survival, OS: Overall Survival, NS: Not significant, /: Not applicable,
*: also significant in multivariate analysis.